Gilpin Wealth Management’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.49M Sell
4,127
-40
-1% -$13.7K 1.03% 25
2026
Q1
$1.47M Sell
4,167
-30
-0.7% -$10.7K 1.16% 22
2025
Q4
$1.37M Buy
+4,197
New +$1.33M 1.09% 26

Other funds holding AMGN

Gilpin Wealth Management's AMGN Position: Q2 2026 in Review

Gilpin Wealth Management reduced its Amgen (AMGN) stake by 0.96% in Q2 2026, selling an estimated $13.7K and leaving 4,127 shares worth $1.49M. The position accounts for 1.03% of the portfolio, ranked #25.

Gilpin Wealth Management first reported a position in AMGN in Q4 2025 and has held it in 3 quarters since. 3,164 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Gilpin Wealth Management held 4,127 shares of Amgen worth $1.49M as of Q2 2026.
  • Gilpin Wealth Management sold 40 Amgen shares in Q2 2026, an estimated $13.7K.
  • Amgen made up 1.03% of Gilpin Wealth Management's portfolio in Q2 2026, its #25 holding.
  • Gilpin Wealth Management first reported a position in Amgen in Q4 2025 and has held it in 3 quarters since.
  • 3,164 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Gilpin Wealth Management's 13F filing for Q2 2026, filed 24 Jul 2026.